↓ Skip to main content

Duchenne Muscular Dystrophy

Overview of attention for book
Cover of 'Duchenne Muscular Dystrophy'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 An Overview of Recent Therapeutics Advances for Duchenne Muscular Dystrophy
  3. Altmetric Badge
    Chapter 2 Clinical Manifestations and Overall Management Strategies for Duchenne Muscular Dystrophy
  4. Altmetric Badge
    Chapter 3 Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies
  5. Altmetric Badge
    Chapter 4 Characterization of the Inflammatory Response in Dystrophic Muscle Using Flow Cytometry
  6. Altmetric Badge
    Chapter 5 Imaging Analysis of the Neuromuscular Junction in Dystrophic Muscle
  7. Altmetric Badge
    Chapter 6 System Biology Approach: Gene Network Analysis for Muscular Dystrophy
  8. Altmetric Badge
    Chapter 7 Proteomic Profiling of the Dystrophin-Deficient Brain
  9. Altmetric Badge
    Chapter 8 Probing the Pathogenesis of Duchenne Muscular Dystrophy Using Mouse Models
  10. Altmetric Badge
    Chapter 9 Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy
  11. Altmetric Badge
    Chapter 10 Designing Effective Antisense Oligonucleotides for Exon Skipping
  12. Altmetric Badge
    Chapter 11 Identification of Splicing Factors Involved in DMD Exon Skipping Events Using an In Vitro RNA Binding Assay
  13. Altmetric Badge
    Chapter 12 The Use of Antisense Oligonucleotides for the Treatment of Duchenne Muscular Dystrophy
  14. Altmetric Badge
    Chapter 13 PMO Delivery System Using Bubble Liposomes and Ultrasound Exposure for Duchenne Muscular Dystrophy Treatment
  15. Altmetric Badge
    Chapter 14 Proton Nuclear Magnetic Resonance (1H NMR) Spectroscopy-Based Analysis of Lipid Components in Serum/Plasma of Patients with Duchenne Muscular Dystrophy (DMD)
  16. Altmetric Badge
    Chapter 15 Test of Antifibrotic Drugs in a Cellular Model of Fibrosis Based on Muscle-Derived Fibroblasts from Duchenne Muscular Dystrophy Patients
  17. Altmetric Badge
    Chapter 16 Flow Cytometry-Defined CD49d Expression in Circulating T-Lymphocytes Is a Biomarker for Disease Progression in Duchenne Muscular Dystrophy
  18. Altmetric Badge
    Chapter 17 Advanced Methods to Study the Cross Talk Between Fibro-Adipogenic Progenitors and Muscle Stem Cells
  19. Altmetric Badge
    Chapter 18 AAV6 Vector Production and Purification for Muscle Gene Therapy
  20. Altmetric Badge
    Chapter 19 From gRNA Identification to the Restoration of Dystrophin Expression: A Dystrophin Gene Correction Strategy for Duchenne Muscular Dystrophy Mutations Using the CRISPR-Induced Deletion Method
  21. Altmetric Badge
    Chapter 20 Erratum to: Functional Analysis of Membrane Proteins Produced by Cell-Free Translation
Attention for Chapter 2: Clinical Manifestations and Overall Management Strategies for Duchenne Muscular Dystrophy
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
96 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Clinical Manifestations and Overall Management Strategies for Duchenne Muscular Dystrophy
Chapter number 2
Book title
Duchenne Muscular Dystrophy
Published in
Methods in molecular biology, January 2018
DOI 10.1007/978-1-4939-7374-3_2
Pubmed ID
Book ISBNs
978-1-4939-7373-6, 978-1-4939-7374-3
Authors

Takeshi Tsuda, Tsuda, Takeshi

Abstract

Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder that causes progressive weakness and wasting of skeletal muscular and myocardium in boys due to mutation of dystrophin. The structural integrity of each individual skeletal and cardiac myocyte is significantly compromised upon physical stress due to the absence of dystrophin. The progressive destruction of systemic musculature and myocardium causes affected patients to develop multiple organ disabilities, including loss of ambulation, physical immobility, neuromuscular scoliosis, joint contracture, restrictive lung disease, obstructive sleep apnea, and cardiomyopathy. There are some central nervous system-related medical problems, as dystrophin is also expressed in the neuronal tissues. Although principal management is to mainly delay the pathological process, an enhanced understanding of underlying pathological processes has significantly improved quality of life and longevity for DMD patients. Future research in novel molecular approach is warranted to answer unanswered questions.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 96 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 14 15%
Student > Master 11 11%
Researcher 9 9%
Student > Postgraduate 6 6%
Student > Doctoral Student 5 5%
Other 13 14%
Unknown 38 40%
Readers by discipline Count As %
Medicine and Dentistry 23 24%
Biochemistry, Genetics and Molecular Biology 15 16%
Nursing and Health Professions 5 5%
Neuroscience 3 3%
Psychology 3 3%
Other 8 8%
Unknown 39 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 June 2018.
All research outputs
#15,438,546
of 24,473,185 outputs
Outputs from Methods in molecular biology
#4,537
of 13,800 outputs
Outputs of similar age
#250,506
of 451,887 outputs
Outputs of similar age from Methods in molecular biology
#438
of 1,482 outputs
Altmetric has tracked 24,473,185 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,800 research outputs from this source. They receive a mean Attention Score of 3.5. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 451,887 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,482 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.